Company Overview
Snapshot
Founded in October 2019 by Elad Meller and Yoel Sasson, CelluFlux operates with 1-10 employees. The company has secured $1.05 million across three funding rounds, with its November 2025 funding round including NetZero Tech Ventures.
Business overview
CelluFlux is an Industrial Technologies company focused on developing an innovative process to convert carbohydrates into AMF, a bio-based material designed to replace petrochemical-derived products. Its core technology produces AMF, which is more stable and easier to purify than HMF, addressing scalability challenges. This material has diverse applications, including as a sweet taste modulator in food and beverages, and as a sustainable building block for monomers used in plastics, polymers, and other value-added materials. The company operates within the Clean Industry Tech sector, specifically focusing on Sustainable Materials & Circularity, and serves industries such as industrial manufacturing (plastics, chemicals, rubber, coatings) and agriculture & food (ingredients, processed foods).
Strategic signal
This investment signals continued investor confidence in CelluFlux's bio-based material technology and its potential to disrupt the petrochemical industry by providing sustainable alternatives. The backing from NetZero Tech Ventures, an incubator, suggests strategic support for the company's development and market entry, reinforcing its forward trajectory in sustainable materials and circularity.
Log in to access full profile ›Company Intelligence Q&A
- What is CelluFlux's primary innovation?
- CelluFlux develops an innovative process to transform carbohydrates into AMF, a unique bio-based material designed to replace many petrochemical-derived products.
- When was CelluFlux founded and by whom?
- CelluFlux was founded in October 2019 by co-founders Elad Meller and Yoel Sasson.
- What are the key applications of CelluFlux's AMF material?
- AMF has potential applications as a sweet taste modulator in food and beverages, and as a safe bio-based building block in the production of monomers for plastics, polymers, and other diverse value-added materials.
- What is CelluFlux's total capital raised to date?
- CelluFlux has raised a total of $1.05 million across three funding rounds.